BioSpace News Archive

Celcuity Inc. announced financial results for the fourth quarter and full year ended December 31, 2021, the design for its pivotal Phase 3 trial for gedatolisib, an investigational pan-PI3K/mTOR inhibitor, and other recent business progress.

According to Emergen Research, the global urgent care apps market size was USD 829.28 million in 2020 and is expected to reach USD 11,119.40 million in 2028 and register a revenue CAGR of 40.2% during the forecast period, 2021-2028.

Increasing prevalence of cardiovascular diseases (CVDs) worldwide and rising demand for virtual cardiology solutions are some key factors expected to drive market revenue growth.

Growing geriatric population and rising prevalence of neurological conditions are among the key factors expected to drive the global market revenue growth.

The Settlement Agreement also calls for the performance of a data audit by Hemostemix in relation to the ACP-01 Data in order to review the ACP-01 Data to be returned to Hemostemix (the “Data Audit”), which Data Audit is currently underway.

Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today financial results for the fourth quarter and full year ended December 31, 2021, and highlighted recent accomplishments.

Sientra, Inc. today announced its financial results for the fourth quarter and full year ended December 31, 2021.

Techcon, part of OK International and Dover (NYSE: DOV), and a leader in precision fluid dispensing technologies, announced the launch of its new TS9800 Series Jet Valve Dispensing System, the fastest known dispensing system available.

DURECT Corporation (Nasdaq: DRRX) today announced that Dr. James E. Brown , President and CEO, will be participating in a panel discussion at the Cantor Virtual Rare Orphan Disease Summit

Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease, today provided business and program updates, and reported financial results for the fourth quarter and full year ended December 31, 2021.